Our previous study has demonstrated that ADAM9 enhances cancer cells’ ability to survive in the blood and promotes metastasis by a plasminogen activator-based pathway in activating the anoikis-resistant gene CDCP114. This evidence concerns the gene ADAM9 and cancer.